MEHMET OKCU

Concepts (519)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rhabdomyosarcoma
15
2025
200
4.190
Why?
Medulloblastoma
23
2024
340
3.370
Why?
Cerebellar Neoplasms
21
2024
285
3.240
Why?
Proton Therapy
22
2024
123
3.090
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
2020
779
2.690
Why?
Craniospinal Irradiation
10
2023
58
2.040
Why?
Cancer Survivors
15
2024
205
1.980
Why?
Antineoplastic Combined Chemotherapy Protocols
13
2024
1236
1.930
Why?
Brain Neoplasms
26
2024
1243
1.910
Why?
Prolotherapy
2
2023
2
1.670
Why?
Tennis Elbow
2
2023
2
1.670
Why?
Rhabdomyosarcoma, Embryonal
5
2024
51
1.550
Why?
Soft Tissue Neoplasms
5
2022
129
1.510
Why?
Neoplasm Recurrence, Local
13
2024
1126
1.450
Why?
Child
114
2025
24439
1.350
Why?
Child, Preschool
76
2025
14043
1.220
Why?
Polymorphism, Genetic
6
2011
810
1.120
Why?
Photons
5
2021
48
1.080
Why?
Glioma
10
2024
500
1.010
Why?
Adolescent
80
2025
19301
1.000
Why?
Survivors
20
2024
339
0.980
Why?
Pituitary Neoplasms
5
2023
84
0.970
Why?
Nocardia Infections
1
2024
15
0.890
Why?
Infant
46
2025
12473
0.880
Why?
Salvage Therapy
2
2024
194
0.880
Why?
Neoplasms
17
2024
2784
0.870
Why?
Fibroma
1
2022
30
0.800
Why?
Humans
143
2025
124482
0.790
Why?
Sarcoma
2
2022
194
0.780
Why?
Central Nervous System Neoplasms
5
2023
197
0.760
Why?
Cranial Irradiation
6
2020
69
0.750
Why?
Female
104
2025
66319
0.730
Why?
Male
100
2025
61053
0.730
Why?
Glutathione Transferase
5
2013
153
0.720
Why?
Hearing Loss
4
2024
132
0.690
Why?
Diagnostic Imaging
3
2022
275
0.690
Why?
Sarcoma, Synovial
4
2024
21
0.670
Why?
Head and Neck Neoplasms
7
2021
495
0.660
Why?
Radiotherapy, Intensity-Modulated
7
2017
70
0.660
Why?
Genetic Predisposition to Disease
11
2023
3138
0.650
Why?
Scoliosis
1
2021
135
0.640
Why?
Genotype
13
2016
2551
0.630
Why?
Birth Weight
5
2015
348
0.630
Why?
Cisplatin
7
2024
236
0.610
Why?
Retrospective Studies
42
2024
16270
0.600
Why?
Ependymoma
6
2023
134
0.580
Why?
Protons
8
2023
91
0.560
Why?
Radiotherapy Dosage
12
2023
187
0.550
Why?
Polymorphism, Single Nucleotide
11
2020
2613
0.530
Why?
Cognition
8
2023
730
0.530
Why?
Prognosis
19
2025
4572
0.520
Why?
Biomarkers, Tumor
9
2025
1460
0.520
Why?
Radiotherapy
3
2014
136
0.510
Why?
Survivorship
4
2024
37
0.510
Why?
Cognition Disorders
7
2017
553
0.500
Why?
Neoplasm, Residual
5
2013
121
0.490
Why?
Glutathione S-Transferase pi
3
2012
25
0.490
Why?
Combined Modality Therapy
13
2021
1242
0.480
Why?
Carcinoma
1
2017
280
0.470
Why?
Craniopharyngioma
4
2023
33
0.470
Why?
Disease-Free Survival
14
2018
860
0.470
Why?
Adult
36
2024
29395
0.460
Why?
Antineoplastic Agents
13
2024
1661
0.450
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
2
2011
70
0.450
Why?
Follow-Up Studies
16
2024
5125
0.440
Why?
Adaptation, Psychological
3
2024
451
0.440
Why?
Cost Savings
1
2014
72
0.430
Why?
Risk Factors
19
2024
10181
0.420
Why?
Proportional Hazards Models
10
2025
1327
0.420
Why?
Mutism
2
2024
29
0.410
Why?
Kaplan-Meier Estimate
9
2021
1020
0.410
Why?
DNA Methylation
5
2020
1004
0.400
Why?
Folic Acid
2
2012
292
0.390
Why?
Quality of Health Care
1
2015
391
0.390
Why?
Ambulatory Care
1
2015
387
0.390
Why?
Bone Marrow
2
2021
325
0.390
Why?
Young Adult
20
2024
8970
0.380
Why?
Neuroblastoma
5
2010
519
0.380
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2021
127
0.370
Why?
Anemia, Iron-Deficiency
2
2024
133
0.360
Why?
Rhabdomyosarcoma, Alveolar
3
2021
37
0.360
Why?
Ultrasonography, Interventional
2
2023
193
0.360
Why?
Radiation Injuries
7
2021
143
0.350
Why?
Attention
3
2019
196
0.350
Why?
Metabolic Networks and Pathways
1
2011
188
0.340
Why?
Treatment Outcome
17
2023
12315
0.340
Why?
Intelligence
3
2023
98
0.330
Why?
Body Height
1
2010
214
0.320
Why?
Models, Genetic
2
2014
759
0.320
Why?
Hypothyroidism
2
2021
93
0.320
Why?
Attention Deficit Disorder with Hyperactivity
2
2011
226
0.310
Why?
Cochlea
2
2024
85
0.310
Why?
Survival Rate
8
2024
2028
0.300
Why?
Glucose
2
2023
883
0.300
Why?
Urogenital Neoplasms
1
2008
16
0.290
Why?
Methylenetetrahydrofolate Dehydrogenase (NAD+)
1
2007
3
0.290
Why?
Genetic Markers
3
2015
606
0.290
Why?
Hodgkin Disease
2
2024
292
0.270
Why?
Disease Progression
6
2023
2040
0.270
Why?
Proto-Oncogene Proteins
3
2022
550
0.260
Why?
Case-Control Studies
12
2015
3269
0.250
Why?
Bone Neoplasms
3
2022
429
0.250
Why?
Texas
11
2023
3588
0.240
Why?
Osteosarcoma
2
2022
258
0.230
Why?
Histocompatibility Antigens Class I
2
2015
96
0.230
Why?
Margins of Excision
1
2024
51
0.230
Why?
Aftercare
2
2017
148
0.230
Why?
Repressor Proteins
2
2022
820
0.230
Why?
Costs and Cost Analysis
2
2015
164
0.220
Why?
Intelligence Tests
3
2022
57
0.220
Why?
Menorrhagia
1
2024
74
0.210
Why?
Isoenzymes
1
2004
228
0.210
Why?
Germinoma
1
2023
31
0.210
Why?
Algorithms
2
2024
1614
0.210
Why?
Medical Oncology
3
2011
212
0.210
Why?
Leuprolide
1
2023
22
0.210
Why?
Ovarian Reserve
1
2023
11
0.210
Why?
Obesity
3
2020
2267
0.210
Why?
Vincristine
4
2021
195
0.200
Why?
Epoxide Hydrolases
2
2013
37
0.200
Why?
Hand Strength
1
2022
40
0.200
Why?
Cognitive Dysfunction
2
2023
233
0.200
Why?
Patient Preference
1
2023
118
0.200
Why?
Tracheostomy
1
2024
193
0.200
Why?
Antineoplastic Agents, Alkylating
4
2021
98
0.200
Why?
Neuroectodermal Tumors, Primitive
2
2012
52
0.190
Why?
Tooth Abnormalities
1
2021
9
0.190
Why?
Xerostomia
1
2021
8
0.190
Why?
Cerebellar Diseases
1
2022
75
0.190
Why?
Fever
1
2024
296
0.190
Why?
Salivary Glands
1
2021
32
0.190
Why?
Multivariate Analysis
6
2017
1419
0.190
Why?
Adrenal Insufficiency
1
2021
29
0.190
Why?
Drug Costs
1
2021
60
0.180
Why?
Cyclophosphamide
3
2021
421
0.180
Why?
Paresis
1
2021
36
0.180
Why?
Optic Nerve Glioma
1
2021
21
0.180
Why?
Hemiplegia
1
2021
42
0.180
Why?
Caregivers
2
2023
578
0.180
Why?
Granuloma, Giant Cell
1
2020
13
0.180
Why?
Denosumab
1
2020
13
0.180
Why?
Sarcoma, Ewing
1
2022
117
0.180
Why?
Language Development Disorders
1
2022
174
0.180
Why?
Adult Survivors of Child Adverse Events
1
2020
15
0.180
Why?
Gadolinium
1
2021
104
0.180
Why?
Neuropsychological Tests
6
2024
925
0.170
Why?
Dactinomycin
2
2021
67
0.170
Why?
Bone Density Conservation Agents
1
2020
52
0.170
Why?
Iron
1
2022
269
0.170
Why?
Radiotherapy, Adjuvant
5
2023
142
0.170
Why?
Immunosuppressive Agents
1
2024
644
0.170
Why?
Carboplatin
2
2017
76
0.170
Why?
Incidence
3
2022
3093
0.170
Why?
Neurofibromatosis 1
1
2020
61
0.160
Why?
Emergency Service, Hospital
2
2024
1088
0.160
Why?
Pain
1
2022
457
0.160
Why?
Neurocognitive Disorders
1
2019
67
0.160
Why?
Metabolome
1
2021
294
0.160
Why?
Neurosurgical Procedures
2
2023
307
0.160
Why?
Infant, Newborn
7
2017
8180
0.150
Why?
Genetic Variation
3
2015
1491
0.150
Why?
Treatment Failure
5
2021
342
0.150
Why?
Membrane Proteins
3
2015
1529
0.150
Why?
Memory, Short-Term
1
2019
140
0.150
Why?
Randomized Controlled Trials as Topic
1
2023
1106
0.150
Why?
Glioblastoma
4
2006
334
0.150
Why?
Social Class
1
2019
191
0.150
Why?
Hearing Loss, Sensorineural
1
2019
141
0.150
Why?
Sarcoma, Alveolar Soft Part
1
2018
10
0.150
Why?
Radiotherapy, Conformal
2
2008
55
0.150
Why?
Metabolomics
1
2021
419
0.150
Why?
Postoperative Complications
4
2024
3066
0.150
Why?
Urinary Bladder Neoplasms
2
2021
549
0.150
Why?
Morbidity
3
2024
244
0.140
Why?
Human Growth Hormone
1
1998
75
0.140
Why?
Polymerase Chain Reaction
3
2008
1583
0.140
Why?
Superoxide Dismutase
2
2015
138
0.140
Why?
Cushing Syndrome
1
2017
17
0.140
Why?
Neoplasm Staging
5
2019
1218
0.140
Why?
Leucovorin
1
2017
50
0.140
Why?
Body Mass Index
2
2020
1556
0.140
Why?
Activities of Daily Living
1
2019
404
0.140
Why?
p21-Activated Kinases
1
2017
58
0.140
Why?
Brain Stem
2
2015
116
0.140
Why?
Fluorouracil
1
2017
128
0.140
Why?
HLA-DQ alpha-Chains
1
2016
17
0.140
Why?
Appendiceal Neoplasms
1
2017
16
0.140
Why?
Registries
3
2019
1419
0.140
Why?
Hyperglycemia
2
2009
222
0.140
Why?
Myelodysplastic Syndromes
1
1998
138
0.130
Why?
Logistic Models
3
2010
1807
0.130
Why?
Xeroderma Pigmentosum Group D Protein
1
2016
21
0.130
Why?
Consensus Development Conferences as Topic
1
2016
39
0.130
Why?
Age Factors
5
2024
2810
0.130
Why?
DNA, Neoplasm
2
2016
301
0.130
Why?
Executive Function
1
2017
105
0.130
Why?
Neuroendocrine Tumors
1
2017
53
0.130
Why?
United States
6
2022
10821
0.130
Why?
Growth Disorders
1
1998
209
0.130
Why?
Middle Aged
10
2024
26511
0.130
Why?
Odds Ratio
5
2015
1250
0.130
Why?
Stroke
1
2023
977
0.130
Why?
Recurrence
3
2023
1423
0.130
Why?
Ear Diseases
1
2015
18
0.120
Why?
Carcinoma, Mucoepidermoid
1
2015
13
0.120
Why?
Bone Marrow Transplantation
1
1998
577
0.120
Why?
Anthracyclines
1
2015
36
0.120
Why?
Brain
4
2023
3004
0.120
Why?
Bone Marrow Examination
2
2005
14
0.120
Why?
Oncogene Proteins, Fusion
2
2015
212
0.120
Why?
Oncogene Fusion
1
2014
22
0.120
Why?
Cyclin B
1
2014
22
0.120
Why?
Iron-Regulatory Proteins
1
2014
5
0.120
Why?
Neoplasm Proteins
3
2018
669
0.120
Why?
Antibiotics, Antineoplastic
1
2015
128
0.110
Why?
Survival Analysis
5
2008
1490
0.110
Why?
Rhabdoid Tumor
1
2014
50
0.110
Why?
Health Services
1
2014
71
0.110
Why?
Filgrastim
1
2014
15
0.110
Why?
Decision Trees
1
2014
49
0.110
Why?
Prostatic Neoplasms
2
2021
1532
0.110
Why?
Tumor Suppressor Proteins
1
2016
467
0.110
Why?
Monte Carlo Method
1
2014
95
0.110
Why?
Outpatients
1
2015
255
0.110
Why?
Leukemia
2
2010
368
0.110
Why?
Infant Food
1
2013
81
0.110
Why?
Granulocyte Colony-Stimulating Factor
1
2014
96
0.110
Why?
Amifostine
2
2010
14
0.110
Why?
Teratoma
1
2014
123
0.110
Why?
Overweight
1
2016
363
0.110
Why?
Consensus
1
2016
634
0.110
Why?
Multicenter Studies as Topic
1
2014
275
0.100
Why?
Aryl Hydrocarbon Hydroxylases
1
2013
43
0.100
Why?
Stroke Volume
1
2015
478
0.100
Why?
Patient Acceptance of Health Care
1
2017
422
0.100
Why?
Biomarkers
1
2021
2989
0.100
Why?
Anti-Bacterial Agents
1
2024
2416
0.100
Why?
Hydrocarbons, Chlorinated
1
2012
11
0.100
Why?
Telomere
1
2013
208
0.100
Why?
Air Pollutants, Occupational
1
2012
18
0.100
Why?
Neoplasms, Second Primary
1
2013
153
0.100
Why?
Surgical Procedures, Operative
1
2014
182
0.100
Why?
Ventricular Dysfunction, Left
1
2015
368
0.100
Why?
Immunohistochemistry
3
2012
1686
0.100
Why?
Genome-Wide Association Study
4
2023
1660
0.100
Why?
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
1
2011
21
0.090
Why?
Prospective Studies
5
2021
6082
0.090
Why?
Haplotypes
1
2013
520
0.090
Why?
Gene-Environment Interaction
1
2012
122
0.090
Why?
Thyroid Neoplasms
1
2013
198
0.090
Why?
Inpatients
1
2015
499
0.090
Why?
Papillomavirus Vaccines
1
2012
94
0.090
Why?
Liposarcoma
1
2011
21
0.090
Why?
Time Factors
4
2024
6285
0.090
Why?
Computer Simulation
1
2014
643
0.090
Why?
Vaccination
1
2016
953
0.090
Why?
Decision Support Techniques
1
2014
290
0.090
Why?
Social Adjustment
2
2022
84
0.090
Why?
Mitogen-Activated Protein Kinase Phosphatases
1
2010
15
0.090
Why?
Chemokines, CXC
1
2010
39
0.090
Why?
Nervous System Diseases
3
2013
376
0.090
Why?
Dual-Specificity Phosphatases
1
2010
22
0.090
Why?
Air Pollutants
1
2012
101
0.090
Why?
Heart Ventricles
1
2015
769
0.090
Why?
Recombinant Proteins
1
2014
1392
0.090
Why?
Gestational Age
2
2015
1161
0.090
Why?
Risk Assessment
2
2014
3392
0.090
Why?
Neoplasm Metastasis
3
2017
664
0.090
Why?
Fetal Macrosomia
1
2010
20
0.080
Why?
Pediatrics
2
2011
1154
0.080
Why?
Prodrugs
1
2010
59
0.080
Why?
Antioxidants
1
2012
336
0.080
Why?
Dacarbazine
1
2009
86
0.080
Why?
Information Dissemination
1
2011
185
0.080
Why?
Tumor Burden
2
2021
228
0.080
Why?
Nerve Sheath Neoplasms
1
2009
23
0.080
Why?
Magnetic Resonance Imaging
4
2021
3575
0.080
Why?
Clinical Trials as Topic
1
2014
1090
0.080
Why?
Uterine Cervical Neoplasms
1
2012
237
0.080
Why?
Oligodendroglioma
2
2010
24
0.080
Why?
In Situ Hybridization, Fluorescence
2
2013
764
0.080
Why?
Practice Guidelines as Topic
2
2024
1261
0.080
Why?
Astrocytoma
2
2013
103
0.080
Why?
Carmustine
2
1999
26
0.080
Why?
Parents
2
2023
1029
0.080
Why?
Ethics, Medical
1
2011
394
0.080
Why?
Spinal Cord Neoplasms
1
2009
71
0.080
Why?
Papillomavirus Infections
1
2012
288
0.080
Why?
Surveys and Questionnaires
3
2023
3724
0.070
Why?
Cyclins
2
1999
101
0.070
Why?
Real-Time Polymerase Chain Reaction
3
2015
510
0.070
Why?
Neutropenia
1
2009
200
0.070
Why?
Quality of Life
3
2023
1944
0.070
Why?
Folic Acid Antagonists
1
2007
16
0.070
Why?
Sex Distribution
2
2013
300
0.070
Why?
Lung Neoplasms
1
2017
1600
0.070
Why?
Thrombocytopenia
1
2009
226
0.070
Why?
Quality Improvement
2
2024
636
0.070
Why?
Sex Characteristics
1
2009
319
0.070
Why?
Syndrome
2
2022
1118
0.070
Why?
Cross-Sectional Studies
4
2019
3426
0.070
Why?
Radiation Oncology
1
2007
23
0.070
Why?
Remission Induction
2
2008
301
0.070
Why?
Guidelines as Topic
1
2008
197
0.070
Why?
Antimetabolites, Antineoplastic
1
2007
181
0.060
Why?
Hospitalization
1
2014
1775
0.060
Why?
Risk
2
2019
750
0.060
Why?
Tumor Suppressor Protein p53
1
2010
720
0.060
Why?
Biomedical Research
1
2011
519
0.060
Why?
Chemotherapy, Adjuvant
2
2010
355
0.060
Why?
Apoptosis
5
2010
1788
0.060
Why?
Vision Disorders
2
2021
212
0.060
Why?
Flow Cytometry
2
2005
802
0.060
Why?
Methotrexate
1
2007
341
0.060
Why?
Telomerase
1
2006
160
0.060
Why?
Hemochromatosis Protein
2
2015
22
0.060
Why?
Predictive Value of Tests
3
2008
2127
0.060
Why?
Mental Disorders
1
2012
824
0.060
Why?
Immunophenotyping
1
2005
329
0.060
Why?
Cohort Studies
4
2019
4751
0.060
Why?
Bone Marrow Neoplasms
1
2004
24
0.060
Why?
Age Distribution
2
2002
414
0.060
Why?
Receptors, CXCR4
1
2004
59
0.060
Why?
Polymorphism, Restriction Fragment Length
1
2004
143
0.060
Why?
Chemoradiotherapy
1
2024
104
0.060
Why?
Radiotherapy Planning, Computer-Assisted
2
2014
63
0.060
Why?
Sensitivity and Specificity
2
2005
2034
0.050
Why?
Genomics
1
2011
1489
0.050
Why?
Antigens, CD
1
2005
422
0.050
Why?
Linear Models
2
2016
672
0.050
Why?
Genes, Immunoglobulin
1
2003
33
0.050
Why?
Chromosomes, Human, Pair 17
1
2005
370
0.050
Why?
Tennessee
1
2003
27
0.050
Why?
Germany
1
2003
66
0.050
Why?
Italy
1
2003
113
0.050
Why?
Anti-Mullerian Hormone
1
2023
37
0.050
Why?
Verbal Learning
1
2022
66
0.050
Why?
Chromosome Aberrations
1
2005
621
0.050
Why?
Time-to-Treatment
1
2024
187
0.050
Why?
Neoplasm Grading
2
2013
266
0.050
Why?
Pulmonary Artery
1
2005
440
0.050
Why?
Confidence Intervals
1
2002
283
0.050
Why?
Probability
1
2002
323
0.050
Why?
Respiration, Artificial
1
2024
461
0.050
Why?
Precision Medicine
1
2025
317
0.050
Why?
Anemia, Sickle Cell
1
2005
339
0.050
Why?
Spinal Cord
1
2023
303
0.050
Why?
Lymphatic Metastasis
2
2018
402
0.050
Why?
RNA, Messenger
5
2009
2823
0.050
Why?
Neoadjuvant Therapy
1
2023
326
0.050
Why?
Hemoglobins
1
2022
303
0.050
Why?
Genetic Association Studies
2
2015
776
0.050
Why?
Emotions
1
2024
364
0.050
Why?
Reoperation
1
2024
831
0.050
Why?
Growth Hormone
1
2021
153
0.050
Why?
Reference Values
1
2002
710
0.050
Why?
Cancer Care Facilities
2
2016
30
0.050
Why?
Hypertension, Pulmonary
1
2005
435
0.040
Why?
Severity of Illness Index
1
2009
2896
0.040
Why?
Analysis of Variance
2
2015
1017
0.040
Why?
Disease Management
1
2024
521
0.040
Why?
Research
1
2022
263
0.040
Why?
Alleles
2
2015
1616
0.040
Why?
Genes, bcl-2
1
1999
10
0.040
Why?
Population Surveillance
1
2002
389
0.040
Why?
Proctitis
1
2019
6
0.040
Why?
Leukemia, Myeloid
1
1999
85
0.040
Why?
Tretinoin
1
1999
116
0.040
Why?
Oligodeoxyribonucleotides, Antisense
1
1999
7
0.040
Why?
Adiposity
1
2020
191
0.040
Why?
Urinary Incontinence
1
2019
70
0.040
Why?
Cost-Benefit Analysis
1
2021
511
0.040
Why?
Cell Line, Tumor
3
2010
3338
0.040
Why?
Cystectomy
1
2019
156
0.040
Why?
Leukocyte Count
1
2019
247
0.040
Why?
Seizures
1
2023
878
0.040
Why?
Psychomotor Performance
1
2019
179
0.040
Why?
Photic Stimulation
1
2019
220
0.040
Why?
Lymphatic Irradiation
1
2018
5
0.040
Why?
Relative Biological Effectiveness
1
2018
6
0.040
Why?
Drug Resistance, Multiple
1
1998
49
0.040
Why?
Interleukin-10
1
1999
173
0.040
Why?
Prostatectomy
1
2019
334
0.040
Why?
DNA-Binding Proteins
1
2006
2057
0.040
Why?
Contrast Media
1
2021
471
0.040
Why?
Pregnancy
3
2015
7169
0.030
Why?
Tumor Cells, Cultured
4
1999
1064
0.030
Why?
Lymphocytes
1
2019
406
0.030
Why?
Neoplasms, Germ Cell and Embryonal
1
2017
89
0.030
Why?
Membrane Glycoproteins
1
1999
412
0.030
Why?
Computational Biology
1
2021
820
0.030
Why?
Colectomy
1
2017
76
0.030
Why?
Neutrophils
1
2019
378
0.030
Why?
Prevalence
2
2016
2442
0.030
Why?
Appendectomy
1
2017
88
0.030
Why?
Visual Acuity
1
2021
824
0.030
Why?
Incidental Findings
1
2017
124
0.030
Why?
Radiation Dosage
1
2016
135
0.030
Why?
Aged
5
2014
19549
0.030
Why?
Lymph Nodes
1
2018
376
0.030
Why?
Sample Size
1
2016
86
0.030
Why?
Longitudinal Studies
1
2019
1322
0.030
Why?
Appendicitis
1
2017
128
0.030
Why?
Hematopoietic Stem Cells
1
1999
543
0.030
Why?
CpG Islands
1
2016
323
0.030
Why?
Salivary Gland Neoplasms
1
2015
55
0.030
Why?
Systole
1
2015
196
0.030
Why?
Hospital Records
1
2014
8
0.030
Why?
Birth Order
1
2014
7
0.030
Why?
Bevacizumab
1
2014
63
0.030
Why?
Pilot Projects
1
2019
1400
0.030
Why?
Blood Glucose
2
2009
1128
0.030
Why?
Observer Variation
1
2015
299
0.030
Why?
Doxorubicin
2
2010
297
0.030
Why?
Maternal Age
1
2014
132
0.030
Why?
Patient Compliance
1
2017
472
0.030
Why?
DNA Repair
2
2012
587
0.030
Why?
Cytochrome P-450 CYP1B1
1
2013
29
0.030
Why?
Endocrine System Diseases
1
2013
39
0.030
Why?
Xenobiotics
1
2013
28
0.030
Why?
HLA Antigens
1
2014
243
0.030
Why?
Affective Symptoms
1
2013
59
0.030
Why?
Radiography
1
2015
827
0.030
Why?
Cell Proliferation
2
2010
2303
0.030
Why?
Promoter Regions, Genetic
1
2016
1341
0.030
Why?
Sex Factors
1
2016
1277
0.030
Why?
Infant Formula
1
2013
99
0.030
Why?
Maternal-Fetal Exchange
1
2013
81
0.030
Why?
Reproducibility of Results
2
2010
2868
0.030
Why?
Genetic Loci
1
2014
333
0.030
Why?
Socioeconomic Factors
1
2016
872
0.030
Why?
Angiogenesis Inhibitors
1
2014
208
0.030
Why?
Glutathione Peroxidase
1
2012
31
0.030
Why?
Gene Frequency
1
2014
718
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2012
29
0.030
Why?
Medical Records
1
2013
191
0.020
Why?
Metabolic Detoxication, Phase I
1
2012
10
0.020
Why?
Metabolic Detoxication, Phase II
1
2012
14
0.020
Why?
Melanoma
1
1999
832
0.020
Why?
Solvents
1
2012
43
0.020
Why?
Consent Forms
1
2011
22
0.020
Why?
Phosphorylation
2
2010
1625
0.020
Why?
Central Nervous System
1
2013
253
0.020
Why?
Diagnosis, Differential
1
2017
1892
0.020
Why?
Genetic Privacy
1
2011
42
0.020
Why?
Mutation
1
2025
5805
0.020
Why?
Poliovirus Vaccines
1
2011
14
0.020
Why?
Single-Blind Method
1
2011
235
0.020
Why?
Haemophilus Vaccines
1
2011
30
0.020
Why?
Drug Resistance, Neoplasm
2
2010
719
0.020
Why?
Premature Birth
1
2015
384
0.020
Why?
Chi-Square Distribution
1
2012
582
0.020
Why?
Chemokine CXCL6
1
2010
16
0.020
Why?
Hepatitis B Vaccines
1
2011
41
0.020
Why?
Platelet Factor 4
1
2010
22
0.020
Why?
Chemokine CXCL12
1
2010
32
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2014
502
0.020
Why?
Tissue Array Analysis
1
2010
137
0.020
Why?
Mercaptoethylamines
1
2010
1
0.020
Why?
Organs at Risk
1
2010
24
0.020
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2009
20
0.020
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2009
26
0.020
Why?
Echocardiography
1
2015
1055
0.020
Why?
Aurora Kinases
1
2009
31
0.020
Why?
Aged, 80 and over
2
2011
6484
0.020
Why?
Serine
1
2010
173
0.020
Why?
Daunorubicin
1
2009
27
0.020
Why?
Pregnancy Complications
1
2014
506
0.020
Why?
Benzazepines
1
2009
64
0.020
Why?
Asparaginase
1
2009
41
0.020
Why?
Regression Analysis
1
2011
775
0.020
Why?
Informed Consent
1
2011
336
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
1999
82
0.020
Why?
Prednisone
1
2009
272
0.020
Why?
Autistic Disorder
1
2011
349
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
65
0.020
Why?
Age of Onset
1
2009
581
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2010
1898
0.020
Why?
Feeding Behavior
1
2013
712
0.020
Why?
Child Advocacy
1
2007
8
0.020
Why?
Dexamethasone
1
2009
273
0.020
Why?
Patient Advocacy
1
2007
61
0.020
Why?
Down-Regulation
2
1999
701
0.020
Why?
Glucocorticoids
1
2009
383
0.020
Why?
Vaccines
1
2011
369
0.020
Why?
Continuity of Patient Care
1
2007
154
0.020
Why?
Biopsy
1
2009
1236
0.020
Why?
Echocardiography, Doppler, Color
1
2005
115
0.020
Why?
Genome, Human
1
2011
1273
0.010
Why?
Thoracic Neoplasms
1
2004
36
0.010
Why?
Abdominal Neoplasms
1
2004
33
0.010
Why?
Epilepsy
1
2011
872
0.010
Why?
Escherichia coli
1
2009
985
0.010
Why?
Mass Screening
1
2008
784
0.010
Why?
Hospitals, University
1
2001
97
0.010
Why?
bcl-Associated Death Protein
1
1999
4
0.010
Why?
Phosphoserine
1
1999
41
0.010
Why?
bcl-X Protein
1
1999
31
0.010
Why?
bcl-2-Associated X Protein
1
1999
70
0.010
Why?
Cytarabine
1
1999
98
0.010
Why?
Antigens, CD34
1
1999
108
0.010
Why?
Fas Ligand Protein
1
1999
33
0.010
Why?
Jurkat Cells
1
1999
77
0.010
Why?
Proto-Oncogene Proteins c-bcl-2
1
1999
173
0.010
Why?
Interleukin-2
1
1999
225
0.010
Why?
DNA, Complementary
1
1999
464
0.010
Why?
Interferon-alpha
1
1999
221
0.010
Why?
Doxycycline
1
1998
117
0.010
Why?
Cell Death
1
1998
240
0.010
Why?
Patient Selection
1
2001
693
0.010
Why?
Interferon-gamma
1
1999
502
0.010
Why?
Acute Disease
1
1999
1108
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
1999
1288
0.010
Why?
Transfection
1
1998
1069
0.010
Why?
Adenoviridae
1
1999
604
0.010
Why?
Genetic Vectors
1
1999
940
0.010
Why?
Gene Expression
1
1999
1570
0.010
Why?
DNA Damage
1
1998
515
0.010
Why?
Carrier Proteins
1
1999
1024
0.010
Why?
OKCU's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (519)
Explore
_
Co-Authors (113)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_